Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Sytl4 | Rat | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | SYTL4 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SYTL4 mRNA | CTD | PMID:22079256 | Sytl4 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Sytl4 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of SYTL4 mRNA | CTD | PMID:22206623 | Sytl4 | Rat | 17alpha-ethynylestradiol | increases expression | ISO | Sytl4 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of SYTL4 mRNA | CTD | PMID:17942748 | Sytl4 | Rat | 17alpha-ethynylestradiol | multiple interactions | ISO | Sytl4 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SYTL4 mRNA | CTD | PMID:17942748 | Sytl4 | Rat | 17beta-estradiol | multiple interactions | ISO | SYTL4 (Homo sapiens) | 6480464 | EGF protein inhibits the reaction [Estradiol results in increased expression of SYTL4 mRNA] | CTD | PMID:24758408 | Sytl4 | Rat | 17beta-estradiol | increases expression | ISO | SYTL4 (Homo sapiens) | 6480464 | Estradiol results in increased expression of SYTL4 mRNA | CTD | PMID:24758408 | Sytl4 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Sytl4 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SYTL4 mRNA | CTD | PMID:17942748 | Sytl4 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SYTL4 mRNA | CTD | PMID:33387578 | Sytl4 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | SYTL4 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SYTL4 mRNA | CTD | PMID:22298810 | Sytl4 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of SYTL4 mRNA | CTD | PMID:22298810 | Sytl4 | Rat | 4-hydroxyphenyl retinamide | increases expression | ISO | Sytl4 (Mus musculus) | 6480464 | Fenretinide results in increased expression of SYTL4 mRNA | CTD | PMID:28973697 | Sytl4 | Rat | 4-hydroxyphenyl retinamide | decreases expression | ISO | Sytl4 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of SYTL4 mRNA | CTD | PMID:28973697 | Sytl4 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of SYTL4 mRNA | CTD | PMID:24780913 | Sytl4 | Rat | acrolein | multiple interactions | ISO | SYTL4 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SYTL4 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SYTL4 mRNA | CTD | PMID:32699268 | Sytl4 | Rat | aflatoxin B1 | decreases methylation | ISO | SYTL4 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of SYTL4 gene | CTD | PMID:27153756 | Sytl4 | Rat | alpha-pinene | multiple interactions | ISO | SYTL4 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SYTL4 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SYTL4 mRNA | CTD | PMID:32699268 | Sytl4 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of SYTL4 mRNA | CTD | PMID:16483693 | Sytl4 | Rat | aristolochic acid A | decreases expression | ISO | SYTL4 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of SYTL4 mRNA | CTD | PMID:33212167 | Sytl4 | Rat | Aroclor 1254 | decreases expression | ISO | Sytl4 (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of SYTL4 mRNA | CTD | PMID:23650126 | Sytl4 | Rat | arsane | multiple interactions | ISO | SYTL4 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SYTL4 mRNA | CTD | PMID:32525701 | Sytl4 | Rat | arsenic atom | multiple interactions | ISO | SYTL4 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SYTL4 mRNA | CTD | PMID:32525701 | Sytl4 | Rat | arsenite(3-) | multiple interactions | ISO | SYTL4 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to SYTL4 mRNA] | CTD | PMID:32406909 | Sytl4 | Rat | benzo[a]pyrene | affects methylation | ISO | SYTL4 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of SYTL4 5' UTR more ... | CTD | PMID:27901495 | Sytl4 | Rat | bis(2-ethylhexyl) phthalate | increases expression | ISO | SYTL4 (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in increased expression of SYTL4 mRNA | CTD | PMID:31163220 | Sytl4 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SYTL4 mRNA | CTD | PMID:25181051 and PMID:31129395 | Sytl4 | Rat | bisphenol A | increases expression | ISO | SYTL4 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of SYTL4 mRNA | CTD | PMID:36232920 | Sytl4 | Rat | bisphenol A | decreases expression | ISO | Sytl4 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of SYTL4 mRNA | CTD | PMID:32156529 | Sytl4 | Rat | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with tributyltin] results in decreased expression of SYTL4 mRNA | CTD | PMID:31129395 | Sytl4 | Rat | carbon nanotube | decreases expression | ISO | Sytl4 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25620056 | Sytl4 | Rat | CGP 52608 | multiple interactions | ISO | SYTL4 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to SYTL4 gene] | CTD | PMID:28238834 | Sytl4 | Rat | chromium(6+) | decreases expression | ISO | SYTL4 (Homo sapiens) | 6480464 | chromium hexavalent ion results in decreased expression of SYTL4 mRNA | CTD | PMID:30690063 | Sytl4 | Rat | copper(II) sulfate | increases expression | ISO | SYTL4 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of SYTL4 mRNA | CTD | PMID:19549813 | Sytl4 | Rat | coumestrol | multiple interactions | ISO | SYTL4 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 more ... | CTD | PMID:19167446 | Sytl4 | Rat | cyclosporin A | decreases expression | ISO | SYTL4 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of SYTL4 mRNA | CTD | PMID:20106945 | Sytl4 | Rat | dorsomorphin | multiple interactions | ISO | SYTL4 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Sytl4 | Rat | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of SYTL4 mRNA | CTD | PMID:29391264 | Sytl4 | Rat | Enterolactone | multiple interactions | ISO | SYTL4 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SYTL4 mRNA | CTD | PMID:19167446 | Sytl4 | Rat | FR900359 | increases phosphorylation | ISO | SYTL4 (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of SYTL4 protein | CTD | PMID:37730182 | Sytl4 | Rat | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of SYTL4 mRNA | CTD | PMID:33387578 | Sytl4 | Rat | linsidomine | increases oxidation | EXP | | 6480464 | linsidomine results in increased oxidation of SYTL4 protein | CTD | PMID:28086193 | Sytl4 | Rat | manganese(II) chloride | increases expression | EXP | | 6480464 | manganese chloride results in increased expression of SYTL4 mRNA | CTD | PMID:28801915 | Sytl4 | Rat | methylmercury chloride | decreases expression | ISO | SYTL4 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of SYTL4 mRNA | CTD | PMID:28001369 | Sytl4 | Rat | N-nitrosodiethylamine | increases expression | ISO | SYTL4 (Homo sapiens) | 6480464 | Diethylnitrosamine results in increased expression of SYTL4 mRNA | CTD | PMID:21527772 | Sytl4 | Rat | ozone | multiple interactions | ISO | SYTL4 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SYTL4 mRNA more ... | CTD | PMID:32699268 | Sytl4 | Rat | panobinostat | multiple interactions | ISO | SYTL4 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYTL4 mRNA | CTD | PMID:27188386 | Sytl4 | Rat | paracetamol | affects expression | ISO | Sytl4 (Mus musculus) | 6480464 | Acetaminophen affects the expression of SYTL4 mRNA | CTD | PMID:17562736 | Sytl4 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of SYTL4 mRNA | CTD | PMID:33387578 | Sytl4 | Rat | paracetamol | decreases expression | ISO | SYTL4 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of SYTL4 mRNA | CTD | PMID:26690555 | Sytl4 | Rat | perfluorohexanesulfonic acid | increases expression | ISO | Sytl4 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of SYTL4 mRNA | CTD | PMID:37995155 | Sytl4 | Rat | pirinixic acid | multiple interactions | ISO | SYTL4 (Homo sapiens) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SYTL4 mRNA | CTD | PMID:19710929 | Sytl4 | Rat | pirinixic acid | increases expression | ISO | Sytl4 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of SYTL4 mRNA | CTD | PMID:20813756 and PMID:23811191 | Sytl4 | Rat | pirinixic acid | multiple interactions | ISO | Sytl4 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SYTL4 mRNA | CTD | PMID:19710929 | Sytl4 | Rat | potassium chromate | multiple interactions | ISO | SYTL4 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SYTL4 mRNA | CTD | PMID:22079256 | Sytl4 | Rat | potassium chromate | decreases expression | ISO | SYTL4 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of SYTL4 mRNA | CTD | PMID:22079256 and PMID:22714537 | Sytl4 | Rat | progesterone | increases expression | ISO | SYTL4 (Homo sapiens) | 6480464 | Progesterone results in increased expression of SYTL4 mRNA | CTD | PMID:20864642 | Sytl4 | Rat | quercetin | increases expression | ISO | SYTL4 (Homo sapiens) | 6480464 | Quercetin results in increased expression of SYTL4 mRNA | CTD | PMID:21632981 | Sytl4 | Rat | resveratrol | multiple interactions | ISO | SYTL4 (Homo sapiens) | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of SYTL4 mRNA | CTD | PMID:19167446 | Sytl4 | Rat | resveratrol | increases expression | ISO | SYTL4 (Homo sapiens) | 6480464 | resveratrol results in increased expression of SYTL4 mRNA | CTD | PMID:19167446 | Sytl4 | Rat | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of SYTL4 protein | CTD | PMID:35544339 | Sytl4 | Rat | SB 431542 | multiple interactions | ISO | SYTL4 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Sytl4 | Rat | silicon dioxide | decreases expression | ISO | SYTL4 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of SYTL4 mRNA | CTD | PMID:25895662 | Sytl4 | Rat | sodium arsenate | multiple interactions | ISO | SYTL4 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SYTL4 mRNA | CTD | PMID:32525701 | Sytl4 | Rat | sodium arsenite | decreases expression | ISO | Sytl4 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of SYTL4 mRNA | CTD | PMID:37682722 | Sytl4 | Rat | succimer | multiple interactions | ISO | SYTL4 (Homo sapiens) | 6480464 | [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SYTL4 mRNA | CTD | PMID:26378955 | Sytl4 | Rat | sunitinib | decreases expression | ISO | SYTL4 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of SYTL4 mRNA | CTD | PMID:31533062 | Sytl4 | Rat | thimerosal | decreases expression | ISO | SYTL4 (Homo sapiens) | 6480464 | Thimerosal results in decreased expression of SYTL4 mRNA | CTD | PMID:27188386 | Sytl4 | Rat | tributylstannane | decreases expression | EXP | | 6480464 | tributyltin results in decreased expression of SYTL4 mRNA | CTD | PMID:31129395 | Sytl4 | Rat | tributylstannane | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with tributyltin] results in decreased expression of SYTL4 mRNA | CTD | PMID:31129395 | Sytl4 | Rat | trichloroethene | decreases methylation | EXP | | 6480464 | Trichloroethylene results in decreased methylation of SYTL4 gene | CTD | PMID:27618143 | Sytl4 | Rat | trichostatin A | increases expression | ISO | SYTL4 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of SYTL4 mRNA | CTD | PMID:24935251 and PMID:26272509 | Sytl4 | Rat | trichostatin A | multiple interactions | ISO | SYTL4 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYTL4 mRNA | CTD | PMID:27188386 | Sytl4 | Rat | triptonide | increases expression | ISO | Sytl4 (Mus musculus) | 6480464 | triptonide results in increased expression of SYTL4 mRNA | CTD | PMID:33045310 | Sytl4 | Rat | tris(2-butoxyethyl) phosphate | affects expression | ISO | SYTL4 (Homo sapiens) | 6480464 | tris(2-butoxyethyl) phosphate affects the expression of SYTL4 mRNA | CTD | PMID:29024780 | Sytl4 | Rat | valproic acid | affects expression | ISO | Sytl4 (Mus musculus) | 6480464 | Valproic Acid affects the expression of SYTL4 mRNA | CTD | PMID:17963808 | Sytl4 | Rat | valproic acid | increases expression | ISO | SYTL4 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of SYTL4 mRNA | CTD | PMID:19101580 more ... | Sytl4 | Rat | valproic acid | multiple interactions | ISO | SYTL4 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYTL4 mRNA | CTD | PMID:27188386 | Sytl4 | Rat | vorinostat | multiple interactions | ISO | SYTL4 (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYTL4 mRNA | CTD | PMID:27188386 | Sytl4 | Rat | vorinostat | increases expression | ISO | SYTL4 (Homo sapiens) | 6480464 | vorinostat results in increased expression of SYTL4 mRNA | CTD | PMID:26272509 and PMID:27188386 | |